Loading...

Alfresa Holdings Corporation

ALFRYPNK
Healthcare
Medical - Distribution
$15.99
$0.00(0.00%)

Alfresa Holdings Corporation (ALFRY) Company Profile & Overview

Explore Alfresa Holdings Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Alfresa Holdings Corporation (ALFRY) Company Profile & Overview

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

SectorHealthcare
IndustryMedical - Distribution
CEOMr. Ryuji Arakawa

Contact Information

81 3 5219 5100
1-1-3 Otemachi, Tokyo, 100-0004

Company Facts

12,517 Employees
IPO DateJan 3, 2018
CountryJP
Actively Trading

Frequently Asked Questions

;